Published • loading... • Updated
MEDSIR reports PHERGain and PHERGain-2 trial results for breast cancer
Summary by Clinical Trials Arena
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
MEDSIR reports PHERGain and PHERGain-2 trial results for breast cancer
MEDSIR has reported data from the PHERGain and PHERGain-2 trials, which focused on targeted therapies in early HER2-positive breast cancer.The post MEDSIR reports PHERGain and PHERGain-2 trial results for breast cancer appeared first on Clinical Trials Arena.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
